About Alto Neuroscience
Alto Neuroscience is a private company based in Mountain View, California. It has reported $143,871,393 raised in four offerings on Form D since November 2023. Its chief executive is Amit Etkin.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 20, 2023 | Nov 27, 2023 | $45,000,223fully sold | 16 | $2.8M | EquityRule 506(b) | Form D ↗ |
| Apr 6, 2022 | Nov 27, 2023 | $59,261,815fully sold | 26 | $2.2M | EquityRule 506(b) | Form D ↗ |
| May 3, 2021 | Nov 27, 2023 | $31,887,138fully sold | 19 | $1.6M | Equity, OptionsRule 506(b) | Form D ↗ |
| Sep 13, 2019 | Nov 27, 2023 | $7,722,217fully sold | 16 | $482K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $143,871,393 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alto Neuroscience's Form D filed Nov 27, 2023.
ML
Michael Liang
Director
AS
Adam Savitz
Executive officer
CC
PC
Po Yu (Jeff) Chen
Director
AD
Andrew Dreyfus
Director
AE
Amit Etkin
Chief Executive Officer and director
AW
Aaron Weaver
Director
NS
Nicholas Smith
Executive officer
GY
Gwill York
Director